
Medicines Patent Pool: Long-Acting Therapeutics
The field of long-acting (LA) therapeutics is emerging as the next frontier for healthcare management. By offering sustained and controlled release of medicines, LA technologies make it easier to achieve optimal dosing targets with less frequent administrations of treatment, thus offering support for smoother condition management. To date, LMICs tend to lag behind when it comes to access to new health solutions, and the Medicines Patent Pool is putting efforts to reduce that lag as much as possible, in collaboration with key stakeholders.
December 2021
Click for full info +Medicines Patent Pool: Long-Acting Therapeutics
December 2021 |
- Long-Acting Therapeutics
- Expanding Access to Long-acting Therapeutics in LMICs
- United States, L/MICs
Full Info:
Resource Type:
Citation:
Authors: Lobna Gaayeb, Long-Acting Technologies Project Manager
Health Risks(s):
- Hepatitis
- HIV
- Malaria
Product type(s):
- Injectables
- MPTs
Topic(s):
- MPTs
- Development
- Trials
Region(s)
- Global
URL of resource: